Filing Details

Accession Number:
0000899243-19-004150
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-19 19:34:20
Reporting Period:
2019-02-15
Accepted Time:
2019-02-19 19:34:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1217234 Caredx Inc. CDNA Services-Medical Laboratories (8071) 943316839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1702824 Brian Michael Bell C/O Caredx, Inc.
3260 Bayshore Boulevard
Brisbane CA 94005
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-15 5,000 $1.00 82,198 No 4 M Direct
Common Stock Acquisiton 2019-02-15 5,694 $2.80 87,892 No 4 M Direct
Common Stock Acquisiton 2019-02-15 13,925 $5.90 101,817 No 4 M Direct
Common Stock Acquisiton 2019-02-15 3,503 $6.31 105,320 No 4 M Direct
Common Stock Disposition 2019-02-15 28,122 $25.40 77,198 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2019-02-15 5,000 $0.00 5,000 $1.00
Common Stock Employee Stock Option (right to buy) Disposition 2019-02-15 5,694 $0.00 5,694 $2.80
Common Stock Employee Stock Option (right to buy) Disposition 2019-02-15 13,925 $0.00 13,925 $5.90
Common Stock Employee Stock Option (right to buy) Disposition 2019-02-15 3,503 $0.00 3,503 $6.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,000 2027-04-21 No 4 M Direct
4,306 2027-09-01 No 4 M Direct
31,075 2027-10-27 No 4 M Direct
10,510 2028-01-19 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.63, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  3. 1/4th of the shares subject to the option vested on April 21, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
  4. 1/2 of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter.
  5. 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
  6. 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.